Uploaded June 2022 | Updated November 2026, 3 hours ago
A groundbreaking clinical trial reported a 100% remission rate in colorectal cancer patients using Dostarlimab, a PD-1 blocking immunotherapy drug.
In this video, Dr. Mobeen Syed delves into:
The mechanism of action of Dostarlimab.
An overview of the clinical trial's design and its remarkable outcomes.
Implications of these findings for the future of colorectal cancer treatment.
Could this signify a transformative moment in cancer therapy? Let's explore the details.
Link to the FDA channel: youtube.com/watch?v=DfdMsAqkneE
🧠Study Links:
Sloan Kettering Report: mskcc.org/news/rectal-cancer-disappears-after-experimental-use-immunotherapy
NEJM Study: nejm.org/doi/pdf/10.1056/NEJMoa2201445?articleTools=true
Want to support this work?
Lifetime Membership Offer: drbeen.com/yt-special-p
Buy Me a Coffee: buymeacoffee.com/DrMobeenSyed
Substack: mobeensyedmd.substack.com
Patreon: patreon.com/mobeensyed
#drbeen #koolbeens #cancer
Disclaimer:
This video is not intended to provide assessment, diagnosis, treatment, or medical advice; it also does not constitute provision of healthcare services. The content provided in this video is for informational and educational purposes only.
Please consult with a physician or healthcare professional regarding any medical or mental health related diagnosis or treatment. No information in this video should ever be considered as a substitute for advice from a healthcare professional.
URL list from Wednesday, Jun. 8 2022
DrBeen: Medical Education Online
drbeen.com
Rectal Cancer Disappears After Experimental Use of Immunotherapy | Memorial Sloan Kettering Cancer Center
mskcc.org/news/rectal-cancer-disappears-after-experimental-use-immunotherapy
PD-1 Blockade in Mismatch Repair–Deficient, Locally Advanced Rectal Cancer
nejm.org/doi/pdf/10.1056/NEJMoa2201445?articleTools=true
Study of Induction PD-1 Blockade in Subjects With Locally Advanced Mismatch Repair Deficient Solid Tumors - Full Text View - ClinicalTrials.gov
clinicaltrials.gov/ct2/show/NCT04165772
Dostarlimab - Wikipedia
en.wikipedia.org/wiki/Dostarlimab
Programmed cell death protein 1 - Wikipedia
en.wikipedia.org/wiki/Programmed_cell_death_protein_1
Structures of PD-1 with its ligands: Sideways and dancing cheek to cheek - PMC
ncbi.nlm.nih.gov/pmc/articles/PMC2492504
Ectodomain - Wikipedia
en.wikipedia.org/wiki/Ectodomain
Treatment | Global Colon Cancer Association
globalcca.org/treatment
Colorectal Cancer Stages | Rectal Cancer Staging | Colon Cancer Staging
cancer.org/cancer/colon-rectal-cancer/detection-diagnosis-staging/staged.html
A groundbreaking clinical trial reported a 100% remission rate in colorectal cancer patients using Dostarlimab, a PD-1 blocking immunotherapy drug.
In this video, Dr. Mobeen Syed delves into:
The mechanism of action of Dostarlimab.
An overview of the clinical trial's design and its remarkable outcomes.
Implications of these findings for the future of colorectal cancer treatment.
Could this signify a transformative moment in cancer therapy? Let's explore the details.
Link to the FDA channel: youtube.com/watch?v=DfdMsAqkneE
🧠Study Links:
Sloan Kettering Report: mskcc.org/news/rectal-cancer-disappears-after-experimental-use-immunotherapy
NEJM Study: nejm.org/doi/pdf/10.1056/NEJMoa2201445?articleTools=true
Want to support this work?
Lifetime Membership Offer: drbeen.com/yt-special-p
Buy Me a Coffee: buymeacoffee.com/DrMobeenSyed
Substack: mobeensyedmd.substack.com
Patreon: patreon.com/mobeensyed
#drbeen #koolbeens #cancer
Disclaimer:
This video is not intended to provide assessment, diagnosis, treatment, or medical advice; it also does not constitute provision of healthcare services. The content provided in this video is for informational and educational purposes only.
Please consult with a physician or healthcare professional regarding any medical or mental health related diagnosis or treatment. No information in this video should ever be considered as a substitute for advice from a healthcare professional.
URL list from Wednesday, Jun. 8 2022
DrBeen: Medical Education Online
drbeen.com
Rectal Cancer Disappears After Experimental Use of Immunotherapy | Memorial Sloan Kettering Cancer Center
mskcc.org/news/rectal-cancer-disappears-after-experimental-use-immunotherapy
PD-1 Blockade in Mismatch Repair–Deficient, Locally Advanced Rectal Cancer
nejm.org/doi/pdf/10.1056/NEJMoa2201445?articleTools=true
Study of Induction PD-1 Blockade in Subjects With Locally Advanced Mismatch Repair Deficient Solid Tumors - Full Text View - ClinicalTrials.gov
clinicaltrials.gov/ct2/show/NCT04165772
Dostarlimab - Wikipedia
en.wikipedia.org/wiki/Dostarlimab
Programmed cell death protein 1 - Wikipedia
en.wikipedia.org/wiki/Programmed_cell_death_protein_1
Structures of PD-1 with its ligands: Sideways and dancing cheek to cheek - PMC
ncbi.nlm.nih.gov/pmc/articles/PMC2492504
Ectodomain - Wikipedia
en.wikipedia.org/wiki/Ectodomain
Treatment | Global Colon Cancer Association
globalcca.org/treatment
Colorectal Cancer Stages | Rectal Cancer Staging | Colon Cancer Staging
cancer.org/cancer/colon-rectal-cancer/detection-diagnosis-staging/staged.html










